MFDS — authorised 9 November 2018
- Marketing authorisation holder: MYLAN IRELAND LTD
- Status: likely_approved
MFDS authorised Yupelri on 9 November 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 9 November 2018.
MYLAN IRELAND LTD holds the South Korean marketing authorisation.